Search

everythinglearnresearchcommunity

for

Search:↓

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Perhexiline can effectively target ovarian cancer cells left after treatment.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Vorasidenib can cause unusual hair growth.

Baricitinib works better than methotrexate for severe alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.